UNSPSC 51281704: Aspoxicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N5O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0745KNO26J, chemically known as glycinamide, n-methyl-d-asparaginyl-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-d-2-(4-hydroxyphenyl)-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as aspoxicillin, which bears US NIH Compound Identifier 71961.

UNSPSC 51281704 Aspoxicillin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities in the dataset are a completed pharmaceutical warehouse piggyback award by the Illinois Department of Public Health (for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, neither aspoxicillin) and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—a public health supply procurement unrelated to the antibiotic class this code nominally covers. State and local governments do purchase antibiotics and related pharmaceutical products through cooperative purchasing agreements and direct procurement, but the recent solicitations tagged to this code do not reflect purchases of aspoxicillin specifically.

The geographic activity shown spans Florida and Illinois, with the Illinois Department of Public Health executing a $2,999,999.11 three-year piggyback contract through the MMCAP Infuse consortium awarded to Chartwell Rx LLC on an IFB basis, and Seminole County issuing an IFB (due July 26, 2023) for naloxone and deactivation systems with quarterly delivery to its Sanford community health facility. The code itself does not show sufficient recent activity to characterize issuing-body concentration or establish a clear pattern of state or local purchasing intent for aspoxicillin-specific procurement.